AI assistant
Synagistics Limited — Major Shareholding Notification 2017
Jul 28, 2017
50674_rns_2017-07-28_7bf9dab6-2972-4bc5-a8e5-bcf9d0447402.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [167 x 63] intentionally omitted <==
OP FINANCIAL INVESTMENTS LIMITED 東英金融投資有限公司 *****
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 1140)
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY A DIRECTOR
This announcement is made voluntarily by OP Financial Investments Limited (the “Company” ) to inform its shareholders and potential investors in relation to the increase in shareholding in the Company by Dr. Liu Zhiwei ( “Dr. Liu” ), an executive director and president of the Company.
The Company was informed by Dr. Liu that he acquired a total of 9,324,000 shares (the “Shares” ) of the Company (the “Acquisition” ), at a total consideration of approximately HK$22,224,536 in the open market during the period from 13 July 2017 to 28 July 2017.
Immediately prior to the Acquisition, Dr. Liu was interested in 182,330,000 Shares, representing approximately 9.61% of the issued share capital of the Company. Immediately after the Acquisition, Dr. Liu was interested in 191,654,000 shares, representing approximately 10.10% of the issued share capital of the Company as at the date of this announcement.
By Order of the Board OP Financial Investments Limited Zhang Gaobo Executive Director & CEO
Hong Kong, 28 July 2017
As at the date of this announcement, the Board comprises four executive Directors, namely, Mr. Zhang Zhi Ping, Mr. Zhang Gaobo, Dr. Liu Zhiwei and Mr. Zhang Weidong; one non-executive Director, namely Dr. Wu Zhong and three independent non-executive Directors, namely, Mr. Kwong Che Keung, Gordon, Professor He Jia and Mr. Wang Xiaojun.